What is Crispr Qc?
Crispr Qc, headquartered in San Diego, California, operates within the dynamic Biotechnology industry. The company is focused on leveraging advanced technologies, likely related to CRISPR gene-editing, to address critical challenges and opportunities in its sector. Its strategic positioning in a hub for life sciences innovation suggests a commitment to cutting-edge research and development, aiming to translate scientific breakthroughs into tangible solutions.
How much funding has Crispr Qc raised?
Crispr Qc has raised a total of $1.6M across 1 funding round:
Angel/Seed
$1.6M
Angel/Seed (2023): $1.6M with participation from Serra Ventures
Key Investors in Crispr Qc
Serra Ventures
Serra Ventures is a venture capital firm specializing in early-stage technology startups, particularly in the AgTech sector. They actively support entrepreneurs and startups seeking investment to foster innovation in technology and agriculture.
What's next for Crispr Qc?
The substantial enterprise-level backing indicates that Crispr Qc is likely entering a phase of accelerated growth and scaling. This capital infusion is expected to fuel further research and development, potentially expanding its product pipeline, enhancing its technological capabilities, and broadening its market reach. The company's trajectory suggests a strategic focus on solidifying its position and driving innovation within the biotechnology field, with future developments poised to capitalize on its recent financial momentum.
See full Crispr Qc company page
